Psychiatry and Neurology, Neurology · Bronx, NY
NPI
1902295165
Since 2015
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
1400 Pelham Pkwy S, Bldg. 1, 3n-21
Bronx, NY, 10461
Phone (718) 918-5640
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
809 services
Medicare patients, 2024
355
Average age 71
Drug cost, 2024
$2.8M
1,833 prescriptions
Company payments, 2025
$3,883
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher Langston was code 99214 (office e&m - established), 316 times for 168 patients. In total Christopher Langston billed 809 services in 17 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 316 | 168 | $79.01 | $25K |
| 99213 Office E&M - Established | Facility | 165 | 126 | $52.33 | $8,635 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 120 | 63 | $14.55 | $1,746 |
| 99204 Office E&M - New | Facility | 47 | 47 | $105.03 | $4,936 |
| 99232 Hospital E&M - Subsequent | Facility | 34 | 33 | $69.57 | $2,366 |
| 99203 Office E&M - New | Facility | 25 | 25 | $61.49 | $1,537 |
| 99222 Hospital E&M - Initial | Facility | 23 | 23 | $116.45 | $2,678 |
| 99215 Office E&M - Established | Facility | 23 | 12 | $113.89 | $2,619 |
| 99231 Hospital E&M - Subsequent | Facility | 16 | 12 | $44.10 | $706 |
By year: 2022 $30K for 347 services; 2023 $26K for 295 services; 2024 $54K for 809 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher Langston prescribed most often to Medicare patients was Gabapentin, with 196 prescriptions and refills. In total Christopher Langston wrote 1,833 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 196 | 330 | 58 | $3,747 |
| Baclofen Generic | 182 | 368 | 53 | $4,487 |
| Dalfampridine Er Dalfampridine | 150 | 204 | 25 | $190K |
| Modafinil Generic | 69 | 69 | Under 11 | $4,721 |
| Teriflunomide Generic | 69 | 97 | Under 11 | $263K |
| Kesimpta Pen Ofatumumab | 69 | 69 | Under 11 | $636K |
| Levetiracetam Generic | 60 | 101 | 24 | $1,691 |
| Tizanidine Hcl Generic | 43 | 71 | 13 | $753 |
| Amlodipine Besylate Generic | 36 | 54 | Under 11 | $132 |
| Lacosamide Generic | 36 | 44 | 12 | $1,530 |
| Lamotrigine Generic | 34 | 44 | Under 11 | $264 |
| Pregabalin Generic | 27 | 51 | Under 11 | $3,181 |
| Divalproex Sodium Generic | 26 | 34 | Under 11 | $674 |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 26 | 26 | Under 11 | $111K |
| Topiramate Generic | 25 | 55 | Under 11 | $384 |
Brand drugs: 348 claims; generic drugs: 1,473 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher Langston $3,883 ($3,883 in general payments such as food, travel and fees) from 15 companies. The largest payer was TG Therapeutics, Inc. with $1,591.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 9 | $1,591 |
| EMD Serono, Inc. MRK.DE | 9 | $650 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $389 |
| Biogen, Inc. BIIB | 12 | $351 |
| Lilly USA, LLC LLY | 5 | $165 |
| Argenx US, Inc. ARGX | 2 | $143 |
| Amgen Inc. AMGN | 7 | $135 |
| Eisai Inc. 4523.T | 1 | $125 |
| ITF Therapeutics LLC | 1 | $95.48 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $57.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.